Merck & Co Inc (LSE:0QAH)
$ 100 0 (0%) Market Cap: 252.20 Bil Enterprise Value: 275.80 Bil PE Ratio: 20.90 PB Ratio: 5.67 GF Score: 87/100

Merck & Co Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Oct 02, 2019 / 06:25PM GMT
Release Date Price: $71.75 (-3.54%)
Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD

Hi. Good afternoon. Thanks for attending the Merck session here. I have Mike Nally, the CMO of Merck. And we're going to a fireside chat. But before we begin, I wanted to see if you had any opening comments or remarks.

Michael T. Nally
Merck & Co., Inc. - CMO & Executive VP

No. I mean it's just wonderful to be here. Thanks for the opportunity, and look forward to a good conversation.

Questions & Answers

Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD

Okay. Great. So the first question I had for you is there's a lot of talk about leadership succession, and I'm curious, any comments from that front? And then the other thing that people ask me a lot is, is transformational M&A possible without a new CEO?

Michael T. Nally
Merck & Co., Inc. - CMO & Executive VP

Well, I think your

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot